2011
DOI: 10.1016/j.bbrc.2010.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Pou3f4 deficiency causes defects in otic fibrocytes and stria vascularis by different mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
22
0
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 27 publications
(27 citation statements)
references
References 28 publications
4
22
0
1
Order By: Relevance
“…Most of these mutations are within the regions that encode the DNA-binding domains of Oct9, and thus, these mutations can severely affect Oct9 DNA binding and its capacity to transactivate target genes (95, 96) such as Epha4 in optic mesenchyme cells (191). The hearing loss associated with nonfunctional Oct9 in humans is consistent with observations in Oct9-deficient mice, which reveal defective otic fibrocytes and stria vascularis in the cochlear lateral wall (192, 193). …”
Section: Pathophysiological Roles Of Oct Proteinssupporting
confidence: 85%
“…Most of these mutations are within the regions that encode the DNA-binding domains of Oct9, and thus, these mutations can severely affect Oct9 DNA binding and its capacity to transactivate target genes (95, 96) such as Epha4 in optic mesenchyme cells (191). The hearing loss associated with nonfunctional Oct9 in humans is consistent with observations in Oct9-deficient mice, which reveal defective otic fibrocytes and stria vascularis in the cochlear lateral wall (192, 193). …”
Section: Pathophysiological Roles Of Oct Proteinssupporting
confidence: 85%
“…11D) or Pou3f4 (Supplementary Fig. 12D,E), which is widely expressed in the otic mesenchyme343536, demonstrating that the multipotent stem/progenitors do not originate from the otic ectoderm-derived Neurod1 + lineage committed progenitors or Pou3f4 + otic mesenchyme. Thus our analyses identify a previously unknown population of multipotent stem/progenitor cells that share some characteristics with glial cells that originate from Eya1 -expressing cells.…”
Section: Resultsmentioning
confidence: 95%
“…Currently, the downstream targets of POU3F4, including gap junction genes and their proposed transcription factors in the cochlear supporting cells, are unknown. Only a few genes have been reported to be involved in fibrocyte differentiation including Otospiralin (Otos) [13] and Tbx18 [14], although Song et al reported that neither Otos nor Tbx18 expression was affected in the spiral ligament of Brn4-deficient mice [15]. Although the entire molecular pathway between Brn4 and the cochlear gap junction has not yet been worked out, our data clearly demonstrated that POU3F4 affects the expression and assembly of the gap junction proteins Cx30 (GJB6) and Cx26 (GJB2) in cochlear supporting cells.…”
Section: Discussionmentioning
confidence: 99%